Antisense Oligonucleotide Inhibition of Serine/Threonine Kinases
- 1 May 1999
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 82 (2-3) , 437-449
- https://doi.org/10.1016/s0163-7258(98)00043-6
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Antisense—Protein Kinase A: A Single-Gene-Based Therapeutic ApproachAntisense and Nucleic Acid Drug Development, 1997
- Overexpresson of RIIβ, Regulatory Subunit of Protein Kinase A in Human Colon Carcinoma Cell Induces Growth Arrest and Phenotypic Changes that are Abolished by Site‐Directed Mutation of RIIβEuropean Journal of Biochemistry, 1996
- Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modificationsNucleic Acids Research, 1996
- The ins and outs of Raf kinasesTrends in Biochemical Sciences, 1994
- Protein kinase C - a question of specificityTrends in Biochemical Sciences, 1994
- Types of cyclic AMP binding proteins in human breast cancersEuropean Journal Of Cancer, 1993
- The MAP kinase cascade is essential for diverse signal transduction pathwaysTrends in Biochemical Sciences, 1993
- Site‐selective 8‐chloroadenosine 3′,5′‐cyclic monophosphate inhibits transformation and transforming growth factor α production in Ki‐ras‐transformed rat fibroblastsFEBS Letters, 1989
- Altered cellular ratio of type I and type II cyclic AMP‐dependent protein kinase in human mammary tumorsFEBS Letters, 1979
- Complementary oligonucleotide binding to transfer RNAJournal of Molecular Biology, 1972